Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system
- PMID: 7059440
- PMCID: PMC1402116
- DOI: 10.1111/j.1365-2125.1982.tb01391.x
Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system
Abstract
1 A new osmotic pressure mediated delivery system for metoprolol (Lopresor Oros) has been evaluated by measuring the haemodynamic effects and pharmacokinetics after single and multiple oral dosing in young healthy volunteers. 2 Similar studies have been carried out in the same group using equivalent single and multiple oral doses of the commercial slow-release preparation (Slow Lopresor). 3 The new osmotic delivery system produces a more uniform haemodynamic response: a plateau metoprolol concentration in plasma is reached about 6 h after dosing and is maintained for 10 h.
Similar articles
-
Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):225S-230S. doi: 10.1111/j.1365-2125.1985.tb02767.x. Br J Clin Pharmacol. 1985. PMID: 4005127 Free PMC article. Clinical Trial.
-
A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):239S-244S. doi: 10.1111/j.1365-2125.1985.tb02769.x. Br J Clin Pharmacol. 1985. PMID: 4005129 Free PMC article.
-
A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.Eur J Clin Pharmacol. 1980 Feb;17(2):87-92. doi: 10.1007/BF00562615. Eur J Clin Pharmacol. 1980. PMID: 7371709
-
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
-
Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.Clin Pharmacokinet. 1991 Nov;21(5):319-30. doi: 10.2165/00003088-199121050-00001. Clin Pharmacokinet. 1991. PMID: 1773547 Review.
Cited by
-
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Chem Rev. 2016 Feb 24;116(4):2602-63. doi: 10.1021/acs.chemrev.5b00346. Epub 2016 Feb 8. Chem Rev. 2016. PMID: 26854975 Free PMC article. Review.
-
Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):225S-230S. doi: 10.1111/j.1365-2125.1985.tb02767.x. Br J Clin Pharmacol. 1985. PMID: 4005127 Free PMC article. Clinical Trial.
-
Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):213S-218S. doi: 10.1111/j.1365-2125.1985.tb02765.x. Br J Clin Pharmacol. 1985. PMID: 4005125 Free PMC article.
-
A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.Br J Clin Pharmacol. 1985;19 Suppl 2(Suppl 2):239S-244S. doi: 10.1111/j.1365-2125.1985.tb02769.x. Br J Clin Pharmacol. 1985. PMID: 4005129 Free PMC article.
-
Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.CNS Drugs. 2017 May;31(5):389-403. doi: 10.1007/s40263-017-0430-3. CNS Drugs. 2017. PMID: 28405886 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources